Aardvark Therapeutics Inc (AARD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 61,641 | 9,735 | 15,559 |
| Marketable Securities | 12,022 | 254 | 546 |
| TOTAL | $74,137 | $10,368 | $16,491 |
| Non-Current Assets | |||
| Other Non-Current Assets | 3,370 | 168 | 266 |
| TOTAL | $3,370 | $168 | $266 |
| Total Assets | $77,507 | $10,536 | $16,757 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 2,298 | 1,035 | 259 |
| Accrued Expenses | 2,291 | 235 | 236 |
| TOTAL | $4,927 | $1,382 | $595 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 467 | 52 | 181 |
| TOTAL | $467 | $52 | $181 |
| Total Liabilities | $5,394 | $1,434 | $776 |
| Shareholders' Equity | |||
| Retained earnings | -58,327 | -37,739 | -30,531 |
| Other shareholders' equity | 126,756 | 43,904 | 43,904 |
| TOTAL | $72,113 | $9,102 | $15,981 |
| Total Liabilities And Equity | $77,507 | $10,536 | $16,757 |